JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
0.5
Cite Score
SJR: 0.129 / SNIP: 0.140
Article Type:
Subject:
Ethics code: IR.IAU.PS.REC.1404.551
History
Received: 2026/03/23 | Accepted: 2026/05/14
Received: 2026/03/23 | Accepted: 2026/05/14
Rights and permissions
Authors
Saeid Shahraki, Mohamadkarim Bahadori, Khalil Alimohammadzadeh *1, Ghasem Begloo-Amin, Abasat Mirzaei
1- , Dr_khalil_amz@yahoo.com
Abstract (18 Views)
Aims This scoping review aims to identify and synthesize the key factors influencing medication adherence among patients with diabetes.
Methods This study was conducted as a scoping review based on the Arksey and O’Malley framework, incorporating the enhancements proposed by Levac et al. The scope of the review was defined using the PCC approach, including patients with all types of diabetes, the concept of medication adherence, and all healthcare delivery settings. A systematic search of PubMed/MEDLINE, Scopus, Web of Science, and SID was performed for Persian- and English-language articles published between 2003 and 2025. Study screening was conducted using the Rayyan platform. In total, 52 eligible studies were included. Data were analyzed through narrative synthesis and inductive content analysis, and the results were reported in accordance with the PRISMA-ScR guideline.
Findings The review findings indicated that factors influencing medication adherence among patients with diabetes can be organized into five main levels: individual and demographic factors, psychological and behavioral factors, treatment-related factors, economic and access-related factors, and systemic factors. These levels encompass a wide range of patient characteristics, treatment attributes, economic and access constraints, and components related to supportive interactions and healthcare system performance.
Conclusion This scoping review demonstrates that medication adherence in patients with diabetes is a multilevel phenomenon shaped by the interaction of individual, psychological, treatment-related, economic, and systemic factors. The application of comprehensive conceptual frameworks may provide a foundation for designing more effective interventions and achieving sustained improvements in medication adherence among patients with diabetes.
Methods This study was conducted as a scoping review based on the Arksey and O’Malley framework, incorporating the enhancements proposed by Levac et al. The scope of the review was defined using the PCC approach, including patients with all types of diabetes, the concept of medication adherence, and all healthcare delivery settings. A systematic search of PubMed/MEDLINE, Scopus, Web of Science, and SID was performed for Persian- and English-language articles published between 2003 and 2025. Study screening was conducted using the Rayyan platform. In total, 52 eligible studies were included. Data were analyzed through narrative synthesis and inductive content analysis, and the results were reported in accordance with the PRISMA-ScR guideline.
Findings The review findings indicated that factors influencing medication adherence among patients with diabetes can be organized into five main levels: individual and demographic factors, psychological and behavioral factors, treatment-related factors, economic and access-related factors, and systemic factors. These levels encompass a wide range of patient characteristics, treatment attributes, economic and access constraints, and components related to supportive interactions and healthcare system performance.
Conclusion This scoping review demonstrates that medication adherence in patients with diabetes is a multilevel phenomenon shaped by the interaction of individual, psychological, treatment-related, economic, and systemic factors. The application of comprehensive conceptual frameworks may provide a foundation for designing more effective interventions and achieving sustained improvements in medication adherence among patients with diabetes.
Send email to the article author